Doubts grow over US FRTB implementation

Fragmented roll-out would price European banks “out of the market”

Supranational rules for EU and US under threat
There are fears for the US’s future participation on supranational rulemaking bodies

European banks and policymakers are increasingly concerned the US may scupper a co-ordinated roll-out of new market risk capital rules. Fears that the US timetable may slip have prompted talk of a further delay to the European Union’s implementation of the regime.

The anti-regulatory rhetoric from the Trump White House – echoed by Republican lawmakers – has stoked fears that the US will renege on agreements made by the Basel Committee on Banking Supervision to implement the rules, known as the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here